MBX is MBX Biosciences, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $61.42. Market cap: $2.96B.
Stock snapshot
| Price | $61.42 |
| Market cap | $2.96B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About MBX
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
Related non-dividend companies
Other non-dividend stocks investors research alongside MBX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is MBX's current stock price?
MBX (MBX Biosciences, Inc.) is currently trading at $61.42.
Does MBX pay a dividend?
MBX (MBX Biosciences, Inc.) does not currently pay a regular dividend.
Track MBX in DiviDrip
Add MBX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search MBX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.